BPH Global Ltd
BP8
Company Profile
Business description
BPH Global Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.
Contact
96 Elizabeth Street
Block Arcade, Office 324, Level 3
MelbourneVIC3000
AUST: +61 390882049
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
31
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,477.30 | 20.70 | -0.24% |
| CAC 40 | 8,141.19 | 90.12 | 1.12% |
| DAX 40 | 22,790.56 | 380.29 | 1.70% |
| Dow JONES (US) | 43,810.49 | 189.33 | 0.43% |
| FTSE 100 | 8,732.37 | 63.70 | 0.73% |
| HKSE | 23,787.93 | 753.91 | 3.27% |
| NASDAQ | 19,269.50 | 243.11 | 1.28% |
| Nikkei 225 | 38,142.37 | 95.42 | -0.25% |
| NZX 50 Index | 12,452.46 | 145.19 | 1.18% |
| S&P 500 | 6,007.46 | 52.21 | 0.88% |
| S&P/ASX 200 | 8,240.70 | 11.20 | -0.14% |
| SSE Composite Index | 3,380.21 | 34.17 | 1.02% |